Biomarker & CDx
September 13, 2021

ESMO – GI 2020

Biomarker & CDx
August 28, 2020

ESMO – GI 2020

Author

Veri’s data platform's goal is to promote progress in precision oncology by collecting up to date predictive biomarkers of drug response. At EMSO-GI 2020, we presented the advances made in the form of cancer-biomarker-drug associations.

ESMO-GI 2020 Biomarker-Drug Associations

The goal of Veri’s data platform is to promote progress in precision oncology by collecting up to date predictive biomarkers of drug response. It collects expert-curated predictive associations (biomarker-cancer-drug) coming from multiple sources like publications, clinical trials or conferences, among others.

Recently, ESMO’s World Congress on Gastrointestinal Cancer (ESMO-GI) took place virtually bringing together the latest achievements in this field. Here, we present the advances made in the form of cancer-biomarker-drug associations, many of which had not been previously reported.

To discover more about ESMO-GI 2020 advances and ultimately the biomarker-drug associations, visit veri.larvol.com. You can access the full plot.ly chart here at: https://chart-studio.plotly.com/~larvol/1/#/


Download attached file

Subscribe to our newsletter

Sign up for our newsletter to get the latest news, updates and high-impact data delivered directly to your inbox.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.